28-09-2017 дата публикации
Номер: KR1020170109214A
Принадлежит:
The present invention relates to a composition for evaluating an effect of an enzyme treatment on a Fabry disease and a composition for diagnosing a Fabry disease, a kit containing the composition, and a method for evaluating the effect of enzyme treatment on the Fabry disease using the composition. In the present invention, an inactive complement component 3b (iC3b) has been discovered as a new biomarker related to a diagnosis and therapeutic effect evaluation of the Fabry disease. An expression level of the iC3b in the Fabry disease is higher than that of normal control, so that the Fabry disease can be diagnosed using the same, and furthermore, an expression pattern of the marker gradually changes in a long term after the treatment with enzyme, which can be used as an important biomarker to elucidate the progress and therapeutic effect. COPYRIGHT KIPO 2017 (A1,A2) Fabry disease patient 1 (B1,B2) Fabry disease patient 2 (C1,C2) Fabry disease patient 3 (D1,D2) Fabry disease patient 4 ( ...
Подробнее